{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T03:12:17Z","timestamp":1788491537983,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","radiographyonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiography"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.radi.2026.103525","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T06:17:20Z","timestamp":1785133040000},"page":"103525","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeted contrast agents for breast cancer imaging: A systematic review of nanoparticle, quantum dot, and ultrasound platforms"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-8001-7856","authenticated-orcid":false,"given":"H.","family":"Jubair","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radi.2026.103525_bib1","series-title":"Breast cancer","year":"2024"},{"key":"10.1016\/j.radi.2026.103525_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2022.110513","article-title":"Contrast-enhanced mammography in breast cancer screening","volume":"156","author":"Coffey","year":"2022","journal-title":"Eur J Radiol"},{"issue":"3","key":"10.1016\/j.radi.2026.103525_bib3","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1148\/radiol.13121606","article-title":"Breast ultrasonography: state of the art","volume":"268","author":"Hooley","year":"2013","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.radi.2026.103525_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13058-020-01292-9","article-title":"Ultrafast dynamic contrast-enhanced breast MRI may generate prognostic imaging markers of breast cancer","volume":"22","author":"Onishi","year":"2020","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.radi.2026.103525_bib5","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ejrad.2019.03.008","article-title":"Nephrotoxicity of iodinated contrast media: from pathophysiology to prevention strategies","volume":"116","author":"Faucon","year":"2019","journal-title":"Eur J Radiol"},{"issue":"41","key":"10.1016\/j.radi.2026.103525_bib6","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202002733","article-title":"Multi-stimuli nanocomposite therapeutic: Docetaxel targeted delivery and synergies in treatment of human breast cancer tumor","volume":"16","author":"Taheri-Ledari","year":"2020","journal-title":"Small"},{"issue":"3","key":"10.1016\/j.radi.2026.103525_bib7","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.1021\/acsami.0c19259","article-title":"Biomimetic \u201cnanoplatelets\u201d as a targeted drug delivery platform for breast cancer theranostics","volume":"13","author":"Li","year":"2021","journal-title":"ACS Appl Mater Interfaces"},{"issue":"5","key":"10.1016\/j.radi.2026.103525_bib8","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.3390\/ijms23052856","article-title":"Nanomedicine-based delivery strategies for breast cancer treatment and management","volume":"23","author":"Tagde","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.radi.2026.103525_bib9","article-title":"Advancements in dextran-based nanocarriers for treatment and imaging of breast cancer","volume":"645","author":"Khan","year":"2023","journal-title":"Int J Pharm"},{"issue":"6","key":"10.1016\/j.radi.2026.103525_bib10","doi-asserted-by":"crossref","first-page":"524","DOI":"10.3390\/pharmaceutics12060524","article-title":"Combination therapy and nanoparticulate systems: smart approaches for the effective treatment of breast cancer","volume":"12","author":"Gadag","year":"2020","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.radi.2026.103525_bib11","doi-asserted-by":"crossref","first-page":"579","DOI":"10.7150\/thno.48811","article-title":"MRI-traceable theranostic nanoparticles for targeted cancer treatment","volume":"11","author":"Anani","year":"2021","journal-title":"Theranostics"},{"issue":"3","key":"10.1016\/j.radi.2026.103525_bib12","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1039\/D0CS00771D","article-title":"Targeted contrast agents and activatable probes for photoacoustic imaging of cancer","volume":"51","author":"Zhao","year":"2022","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.radi.2026.103525_bib13","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.3389\/fonc.2020.01131","article-title":"Theranostic pretargeting drug delivery and imaging platforms in cancer precision medicine","volume":"10","author":"Hapuarachchige","year":"2020","journal-title":"Front Oncol"},{"issue":"3","key":"10.1016\/j.radi.2026.103525_bib14","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3390\/pharmaceutics13030296","article-title":"Inorganic nanoparticles applied for active targeted photodynamic therapy of breast cancer","volume":"13","author":"Montaseri","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.radi.2026.103525_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2021.213971","article-title":"New advances in pre-clinical diagnostic imaging perspectives of functionalized upconversion nanoparticle-based nanomedicine","volume":"440","author":"Ansari","year":"2021","journal-title":"Coord Chem Rev"},{"issue":"8","key":"10.1016\/j.radi.2026.103525_bib16","doi-asserted-by":"crossref","first-page":"e393","DOI":"10.1097\/RLU.0000000000003678","article-title":"Theranostic approach in breast cancer: a treasured tailor for future oncology","volume":"46","author":"Jokar","year":"2021","journal-title":"Clin Nucl Med"},{"issue":"19","key":"10.1016\/j.radi.2026.103525_bib17","doi-asserted-by":"crossref","first-page":"6473","DOI":"10.3390\/molecules27196473","article-title":"Biomimetic targeted theranostic nanoparticles for breast cancer treatment","volume":"27","author":"Marshall","year":"2022","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.radi.2026.103525_bib18","doi-asserted-by":"crossref","first-page":"956","DOI":"10.7150\/thno.38288","article-title":"Imaging-assisted anticancer nanotherapy","volume":"10","author":"Dasgupta","year":"2020","journal-title":"Theranostics"},{"issue":"5","key":"10.1016\/j.radi.2026.103525_bib19","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.3390\/cancers14051198","article-title":"Actively targeted nanomedicines in breast cancer: from pre-clinal investigation to clinic","volume":"14","author":"Fraguas-S\u00e1nchez","year":"2022","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.radi.2026.103525_bib20","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1016\/S1470-2045(21)00577-5","article-title":"Clinical advances in PET-MRI for breast cancer","volume":"23","author":"Fowler","year":"2022","journal-title":"Lancet Oncol"},{"issue":"7","key":"10.1016\/j.radi.2026.103525_bib21","doi-asserted-by":"crossref","first-page":"760","DOI":"10.3390\/bioengineering10070760","article-title":"Recent advances in nanomaterials-based targeted drug delivery for preclinical cancer diagnosis and therapeutics","volume":"10","author":"Tiwari","year":"2023","journal-title":"Bioengineering"},{"issue":"10","key":"10.1016\/j.radi.2026.103525_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/aisy.202000087","article-title":"Engineering intelligent nanosystems for enhanced medical imaging","volume":"2","author":"van Moolenbroek","year":"2020","journal-title":"Adv Intell Syst"},{"issue":"11","key":"10.1016\/j.radi.2026.103525_bib23","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.2174\/1381612826666200318170716","article-title":"Nanomedicines in diagnosis and treatment of cancer: an update","volume":"26","author":"Nafis","year":"2020","journal-title":"Curr Pharm Des"},{"issue":"19","key":"10.1016\/j.radi.2026.103525_bib24","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1021\/acs.accounts.2c00346","article-title":"Targeted contrast agents for magnetic resonance molecular imaging of cancer","volume":"55","author":"Lu","year":"2022","journal-title":"Acc Chem Res"},{"issue":"10","key":"10.1016\/j.radi.2026.103525_bib25","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.3390\/cancers14102424","article-title":"HER-2-targeted nanoparticles for breast cancer diagnosis and treatment","volume":"14","author":"Sitia","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.radi.2026.103525_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.jphotobiol.2020.112110","article-title":"Multifunctional nanoparticles as theranostic agents for therapy and imaging of breast cancer","volume":"218","author":"Fernandes","year":"2021","journal-title":"J Photochem Photobiol, B"},{"issue":"1","key":"10.1016\/j.radi.2026.103525_bib27","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1039\/D0NR05489E","article-title":"Silver telluride nanoparticles as biocompatible and enhanced contrast agents for X-ray imaging: an in vivo breast cancer screening study","volume":"13","author":"Nieves","year":"2021","journal-title":"Nanoscale"},{"issue":"5","key":"10.1016\/j.radi.2026.103525_bib28","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1002\/jmri.27241","article-title":"Evaluating the relationship between dynamic contrast-enhanced MRI (DCE-MRI) parameters and pathological characteristics in breast cancer","volume":"52","author":"Kang","year":"2020","journal-title":"J Magn Reson Imaging"},{"issue":"1","key":"10.1016\/j.radi.2026.103525_bib29","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s11671-024-04095-5","article-title":"Theranostics: aptamer-assisted carbon nanotubes as MRI contrast and photothermal agent for breast cancer therapy","volume":"19","author":"Khajuria","year":"2024","journal-title":"Discov Nano"},{"issue":"10","key":"10.1016\/j.radi.2026.103525_bib30","article-title":"Emergence of quantum dots as innovative tools for early diagnosis and advanced treatment of breast cancer","volume":"19","author":"D\u00edaz-Garc\u00eda","year":"2024","journal-title":"ChemMedChem"},{"issue":"10","key":"10.1016\/j.radi.2026.103525_bib31","first-page":"195","article-title":"Construction of nucleolin-targeted lipid nanobubbles and contrast-enhanced ultrasound molecular imaging in triple-negative breast cancer","volume":"37","author":"Fang","year":"2020","journal-title":"Pharm Res"},{"issue":"32","key":"10.1016\/j.radi.2026.103525_bib32","article-title":"A biodegradable \u201cone-for-all\u201d nanoparticle for multimodality imaging and enhanced photothermal treatment of breast cancer","volume":"12","author":"Hsu","year":"2023","journal-title":"Adv Healthc Mater"},{"issue":"4","key":"10.1016\/j.radi.2026.103525_bib33","article-title":"Cell-derived biomimetic 2D nanoparticles to improve cell-specific targeting and tissue penetration for enhanced magnetic resonance imaging","volume":"9","author":"Zhang","year":"2022","journal-title":"Adv Mater Interfaces"}],"container-title":["Radiography"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078817426002014?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078817426002014?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T02:17:37Z","timestamp":1788488257000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078817426002014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1078817426002014"],"URL":"https:\/\/doi.org\/10.1016\/j.radi.2026.103525","relation":{},"ISSN":["1078-8174"],"issn-type":[{"value":"1078-8174","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted contrast agents for breast cancer imaging: A systematic review of nanoparticle, quantum dot, and ultrasound platforms","name":"articletitle","label":"Article Title"},{"value":"Radiography","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radi.2026.103525","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The College of Radiographers. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103525"}}